<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Biotherapy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Biotherapy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский биотерапевтический журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9784</issn><issn publication-format="electronic">1726-9792</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">827</article-id><article-id pub-id-type="doi">10.17650/1726-9784-2016-15-3-90-94</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>BRIEF REPORT</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">CHANGES IN THE MORPHOLOGICAL AND IMMUNOLOGICAL CHARACTERISTICS OF MEL CHER MELANOMA CELLS IN RESPONSE TO LOW CONCENTRATION OF EMBRYO CALF SERUM</article-title><trans-title-group xml:lang="ru"><trans-title>ИЗМЕНЕНИЕ МОРФОЛОГИЧЕСКИХ И ИММУНОЛОГИЧЕСКИХ ХАРАКТЕРИСТИК КЛЕТОК МЕЛАНОМНОЙ ЛИНИИ MEL CHER ПРИ КУЛЬТИВИРОВАНИИ В РОСТОВОЙ СРЕДЕ С НИЗКОЙ КОНЦЕНТРАЦИЕЙ ЭМБРИОНАЛЬНОЙ ТЕЛЯЧЬЕЙ СЫВОРОТКИ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Morozova</surname><given-names>L. F.</given-names></name><name xml:lang="ru"><surname>Морозова</surname><given-names>Л. Ф.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Suraeva</surname><given-names>N. M.</given-names></name><name xml:lang="ru"><surname>Сураева</surname><given-names>Наталья Михайловна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>nsuraeva@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Burova</surname><given-names>O. S.</given-names></name><name xml:lang="ru"><surname>Бурова</surname><given-names>О. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Barmashov</surname><given-names>A. E.</given-names></name><name xml:lang="ru"><surname>Бармашов</surname><given-names>А. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Baryshnikova</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Барышникова</surname><given-names>М. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><institution>ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» Минздрава России</institution></aff><pub-date date-type="pub" iso-8601-date="2016-09-30" publication-format="electronic"><day>30</day><month>09</month><year>2016</year></pub-date><volume>15</volume><issue>3</issue><fpage>90</fpage><lpage>94</lpage><history><date date-type="received" iso-8601-date="2018-04-10"><day>10</day><month>04</month><year>2018</year></date></history><permissions/><self-uri xlink:href="https://bioterapevt.abvpress.ru/jour/article/view/827">https://bioterapevt.abvpress.ru/jour/article/view/827</self-uri><abstract xml:lang="en"><p>Background. Human melanoma cell line mel Cher have a different cell forms and is appraised for grade of differentiation as low-diffe-rentiation melanoma. Objective. The purpose of this study was development and characterization of subclone mel Cher 5C. Materials and methods. For received subclone mel Cher 5C was applied method of colony formation in conditions with low concentration of embryo calf serum (5 %). Then was carry out selection spindle-like cells, their long cultivation and estimate morphological and immunological characteristics. Results. Subclone mel Cher 5C cells differed for morphology from primary line mel Cher. This cells had spindle-like form and had capacity to form spherical type colony on the surface of monolayer during their growth. Subclone cells has more intensive growth compare with cells of primary line. Subclone cells had differences by immunological phenotype and didn’t expressed antigene HLA-DR. Conclusions. Subclone cells had a fusiform shape, in the growth process of the formed spheroid colonies monomorphic type, did not Express antigens of histocompatibility complex II.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="ru"><kwd>эмбриональная телячья сыворотка</kwd><kwd>опухолевая стволовая клетка</kwd><kwd>клетки линии меланомы</kwd><kwd>субклон</kwd><kwd>embryo calf serum</kwd><kwd>cancer stem cells</kwd><kwd>melanoma cell line</kwd><kwd>subclone</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Геращенко Т.С., Денисов Е.В., Литвяков Н.В. и др. Внутриопухолевая гетерогенность: природа и биологическое значение. Биохимия 2013; 78(11): 1531-49.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Iwasaki H., Suda T. Cancer stem sells and thear niche. Cancer Sci 2009; 100(7): 1166-1172. DOI: 10.1111/j.1349-7006.2009.01177.x. PMID: 19432904.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Сураева Н.М., Морозова Л.Ф., Самойлов А.В. и др. Изменение морфологических и иммунологических характеристик клеток меланомной линии mel Ibr в результате воздействия куриного эмбрионального экстракта. Бюллетень экспериментальной биологии и медицины 2015; 159(4): 521-4.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Сураева Н.М., Морозова Л.Ф., Бурова О.С. и др. Изменение морфологических, иммунологических и генетических характеристик клеток меланомной линии mel Ibr при культивировании в ростовой среде с низкой концентрацией эмбриональной телячьей сыворотки. Российский биотерапевтический журнал 2016; 2: 19-23.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Патент № 2364624 РФ Клеточная линия меланомы человека mel Cher, используемая для получения противоопухолевых вакцин. Михайлова И.Н., Барышников А.Ю., Демидов Л.В. и др.; опубл. 20.08.2009. Бюллетень № 23.</mixed-citation></ref></ref-list></back></article>
